Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 6/2014

01-12-2014 | Maternal-Fetal Medicine

Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status

Authors: Meric Karacan, Melike Batukan, Ziya Çebi, Munip Berberoglugil, Semra Levent, Mustafa Kır, Alpaslan Baksu, Emine Ozel, Teksen Camlıbel

Published in: Archives of Gynecology and Obstetrics | Issue 6/2014

Login to get access

Abstract

Purpose

To determine the prevalence of acute cytomegalovirus (CMV), rubella and T. gondii infections among pregnant women who had no serological status tested for these microorganisms prior to pregnancy in a metropolitan area.

Methods

A cross-sectional study was undertaken between January 2009 and January 2013 in 1,258 women presenting for their first antenatal visit (between 6 and 11 weeks of gestation). All women were tested for IgG and IgM antibodies. Subsequently, avidity test was utilized for inconclusive results. They were followed until delivery and all newborns were examined by a pediatrician.

Results

Presence of IgM antibody positivity alone was not detected in any women. Avidity test excluded primary infection in 15 out of 16 (93.7 %) women who were positive for both IgG and IgM antibodies. Amniocentesis was performed in one case with borderline IgG avidity for T. gondii. No primary infections were detected in any newborn for the infections screened. The prevalences of IgG antibodies were 95 % for rubella, 84.1 % for CMV and 23.1 % for T. gondii.

Conclusions

Assessment of IgG and IgM antibodies followed by IgG avidity testing for inconclusive results may be an acceptable approach in pregnant women with unknown serological status prior to pregnancy. Utilization of IgG avidity as a supplemental test prevented unnecessary intervention in IgG and IgM antibodies positive patients. No primary infection was detected for CMV, rubella and T. gondii infections in the urban population screened.
Literature
1.
Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93–99PubMedCrossRef
2.
Nyholm JL, Scheiss MR (2010) Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health 2:23–35PubMedCentralPubMed
3.
Sonoyama A, Ebina Y, Morioka I, Tanimura K, Morizane M, Tairaku S, Minematsu T, Inoue N, Yamada H (2012) Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection. J Med Virol 84(12):1928–1933PubMedCrossRef
4.
Johnson JM, Anderson BL (2013) Cytomegalovirus: should we screen pregnant women for primary infection? Am J Perinatol 30(2):121–124PubMedCrossRef
5.
Miller E, Cradock-Watson JE, Pollock TM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2(8302):781–784PubMedCrossRef
6.
Hermann KL (1985) Available rubella serologic tests. Rev Infect Dis 7:109–114CrossRef
7.
Hamkar R, Jalilvand S, Mokhtari-Azad T, Nouri Jelyani K, Dahi-Far H, Soleimanjahi H, Nategh R (2005) Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine. J Virol Methods 130(1–2):59–65PubMedCrossRef
8.
Montoya J (2002) Laboratory diagnosis of Toxoplasma Gondii infection and toxoplasmosis. J Infect Dis 185:S73–S82PubMedCrossRef
9.
Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS (2001) Effect of testing for IgG avidity in the diagnosis of T. Gondii infection in pregnant women. Experience in a US reference laboratory. J Infect Dis 183:1248–1253PubMedCrossRef
10.
Tanyuksel M, Guney C, Araz E, Saracli MA, Doganci L (2004) Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis. J Microbiol 42(3):211–215PubMed
11.
Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP (1997) Avidity of Immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol 4(4):469–473PubMedCentralPubMed
12.
Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 26:1008–1011CrossRef
13.
Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ (2011) National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 18(11):1895–1899PubMedCentralPubMedCrossRef
14.
Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N (2008) Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 198(4):380PubMedCrossRef
15.
Lazzarotto T, Varani S, Spezzacatena P, Gabrielli L, Pradelli P, Guerra B, Landini MP (2000) Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 13:137–141PubMedCrossRef
16.
Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 43:1152–1153CrossRef
17.
Munro SC, Hall B, Whybin LR, Munro SC, Hall B, Whybin LR (2005) Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 43:4713–4718PubMedCentralPubMedCrossRef
18.
Wong A, Tarık KH, Tee Cs, Yeo GSH (2000) Seroprevalence of cytomegalovirus, Toxoplasma and parvovirus in pregnancy. Singapore Med J 41:151–155PubMed
19.
Uyar Y, Balcı A, Akcalı A, Cabar C (2008) Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol 31:451–455PubMed
20.
Tamer GS, Dundar D, Calıskan E (2008) Seroprevalence of T. Gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 32:E43–E47
21.
Uysal A, Taner CE, Cüce M, Atalay S, Göl B, Köse S, Uysal F (2012) Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet 286(3):605–608PubMedCrossRef
22.
Tipple GA (2011) Rubella diagnostic issues in Canada. J Infect Dis 1(204 Suppl 2):S659–S663CrossRef
23.
Danovaro-Holliday MC, LeBaron CW, Allensworth C, Raymond R, Borden TG, Murray AB et al (2000) A large rubella outbreak with spread from the workplace to the community. JAMA 284:2733–2739PubMedCrossRef
24.
Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC, Lo Giudice D (2012) Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet 116(3):211–213PubMedCrossRef
25.
Pedranti MS, Adamo MP, Macedo R, Zapata MT (2007) Prevalence of anti-rubella and anti-parvovirus B19 antibodies in pregnant women in the city of Cordoba, and in women of fertile age in the city of Villa Mercedes, province of San Luis. Rev Argent Microbiol 39:47–50PubMed
26.
Böttiger B, Jensen IP (1997) Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol 8(2):105–111PubMedCrossRef
27.
28.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE (1999) Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833PubMedCrossRef
29.
Jeannel D, Costagliola D, Niel G, Hubert B, Danis M (1990) What is known about the prevention of congenital toxoplasmosis? Lancet 336:359–361PubMedCrossRef
30.
Paquet C, Yudin MH (2013) Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can 35(1):78–79PubMed
31.
Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154:357–365PubMedCrossRef
32.
Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ (2005) Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epdemiol Infect 3:475–483CrossRef
33.
Gutierrez-Zufiaurre N, Sanchez-Hernandez J, Munoz Marín R, Delgado N, Sáenz MC et al (2004) Seroprevalence of antibodies against Treponema pallidum, T. gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Inf Microbiol Clin 22:512–516CrossRef
34.
Onadeko MO, Joynson DH, Payne RA, Francis J (1996) The prevalence of Toxoplasma antibodies in pregnant Nigerian women and the occurrence of stillbirth and congenital malformation. African J Med Sci 25:331–334
35.
Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E (2013) Comparison of four commercially available avidity tests for T. gondii-specific IgG antibodies. Clin Vaccine Immunol 20(2):197–204PubMedCentralPubMedCrossRef
36.
Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A et al (1999) Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 181:843–848PubMedCrossRef
Metadata
Title
Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status
Authors
Meric Karacan
Melike Batukan
Ziya Çebi
Munip Berberoglugil
Semra Levent
Mustafa Kır
Alpaslan Baksu
Emine Ozel
Teksen Camlıbel
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 6/2014
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3340-3

Other articles of this Issue 6/2014

Archives of Gynecology and Obstetrics 6/2014 Go to the issue

Maternal-Fetal Medicine

MR angiography demonstrates a positive correlation between placental blood vessel volume and fetal size

Gynecologic Endocrinology and Reproductive Medicine

Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET

Gynecologic Oncology

Factors predicting nodal metastasis in endometrial cancer

General Gynecology

A national questionnaire survey of consultants and middle grade doctors’ perception of foundation doctors in obstetrics and gynaecology in the United Kingdom

News and Views

Preterm infants, kidney, rickets and vitamin D intake: is it time for rewriting the history?

General Gynecology

Identification of differentially expressed proteins in the ovaries of menopausal women